【结 构 式】 |
【分子编号】63557 【品名】ethyl 2-({2-[(2,2-dimethoxyethyl)amino]-2-oxoacetyl}amino)acetate 【CA登记号】 |
【 分 子 式 】C10H18N2O6 【 分 子 量 】262.2628 【元素组成】C 45.8% H 6.92% N 10.68% O 36.6% |
合成路线1
该中间体在本合成路线中的序号:(XIV)Acylation of glycine ethyl ester (X) with ethyl oxalyl chloride (XI) provides the oxalic acid mono-amide (XII). Subsequent condensation of (XII) with aminoacetaldehyde dimethylacetal (XIII) affords the diamide (XIV). Cyclization of (XIV) under acetal hydrolysis conditions leads to pyrazinone (XV). This is then brominated to (XVI) employing POBr3 in refluxing dichloroethane. Condensation of the bromopyrazinone (XVI) with amine (IX) at 120 C in a sealed vessel furnishes the aminopyrazinone (XVII). After chlorination of (XVII) with N-chlorosuccinimide, the resultant chloropyrazine ester (XVIII) is hydrolyzed to acid (XIX) under alkaline conditions
【1】 Selnick, H.G.; Rittle, K.E.; Barrow, J.C.; Morrissette, M.M.; Nantermet, P.G.; Staas, D. (Merck & Co., Inc.); Thrombin inhibitors. WO 0257225 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IX) | 63218 | 2-(2-amino-1,1-difluoroethyl)-1-pyridiniumolate | C7H8F2N2O | 详情 | 详情 | |
(X) | 10309 | ethyl 2-aminoacetate; Glycine ethyl ester | 459-73-4 | C4H9NO2 | 详情 | 详情 |
(XI) | 11043 | Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride | 4755-77-5 | C4H5ClO3 | 详情 | 详情 |
(XII) | 63556 | ethyl 2-[(2-ethoxy-2-oxoethyl)amino]-2-oxoacetate | C8H13NO5 | 详情 | 详情 | |
(XIII) | 34158 | aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine | 22483-09-6 | C4H11NO2 | 详情 | 详情 |
(XIV) | 63557 | ethyl 2-({2-[(2,2-dimethoxyethyl)amino]-2-oxoacetyl}amino)acetate | C10H18N2O6 | 详情 | 详情 | |
(XV) | 63558 | ethyl 2-[2,3-dioxo-3,4-dihydro-1(2H)-pyrazinyl]acetate | C8H10N2O4 | 详情 | 详情 | |
(XVI) | 63219 | ethyl 2-[3-bromo-2-oxo-1(2H)-pyrazinyl]acetate | C8H9BrN2O3 | 详情 | 详情 | |
(XVII) | 63220 | 2-(2-{[4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate | C15H16F2N4O4 | 详情 | 详情 | |
(XVIII) | 63221 | 2-(2-{[5-chloro-4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate | C15H15ClF2N4O4 | 详情 | 详情 | |
(XIX) | 63222 | 2-(2-{[4-(carboxymethyl)-5-chloro-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate | C13H11ClF2N4O4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)Acylation of glycine ethyl ester (I) with ethyl oxalyl chloride (II) affords amide (III). Subsequent reaction of (III) with aminoacetaldehyde dimethyl acetal (IV) produces the oxalic acid diamide (V). Cyclization of (V) under acidic conditions furnishes the pyrazine dione (VI), which is further brominated to (VII) employing phosphorus oxybromide.
【1】 Selnick, H.G.; Newton, R.C.; Newton, C.L.; Barrow, J.C.; Nantermet, P.G. (Merck & Co., Inc.); Thrombin inhibitors. WO 0311222 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10309 | ethyl 2-aminoacetate; Glycine ethyl ester | 459-73-4 | C4H9NO2 | 详情 | 详情 |
(II) | 11043 | Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride | 4755-77-5 | C4H5ClO3 | 详情 | 详情 |
(III) | 63556 | ethyl 2-[(2-ethoxy-2-oxoethyl)amino]-2-oxoacetate | C8H13NO5 | 详情 | 详情 | |
(IV) | 34158 | aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine | 22483-09-6 | C4H11NO2 | 详情 | 详情 |
(V) | 63557 | ethyl 2-({2-[(2,2-dimethoxyethyl)amino]-2-oxoacetyl}amino)acetate | C10H18N2O6 | 详情 | 详情 | |
(VI) | 63558 | ethyl 2-[2,3-dioxo-3,4-dihydro-1(2H)-pyrazinyl]acetate | C8H10N2O4 | 详情 | 详情 | |
(VII) | 63219 | ethyl 2-[3-bromo-2-oxo-1(2H)-pyrazinyl]acetate | C8H9BrN2O3 | 详情 | 详情 |